October 2009, US FDA grants Candesartan Cilexetil new indication label of pediatric hypertension (children > 1 year). (www.fda.com). Blopress® Plus (Candesartan cilexetil & HCTZ) is available in 10 countries in Middle East & North Africa. Recently it is launched in Algeria & Egypt.